Tetsuya TSUKAMOTO is a full time Professor in the Department of Diagnostic Pathology, Fujita Health University School of Medicine, Toyoake, Japan. Medical Doctor (1987) in Mie University School of Medicine, Tsu, Japan and Doctor of Philosophy (1991) in Mie University Graduate School of Medicine, Tsu, Japan. Worked in cancer research in Aichi Cancer Center Research Institute, Nagoya, Japan, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA, and University of California at Berkeley, Berkeley, CA, USA. Involved in Pathological field in Division of Oncological Pathology, Aichi Cancer Center Research Institute, Nagoya and Department of Diagnostic Pathology, Fujita Health University School of Medicine, Toyoake, Japan, steering the clinical, teaching, training and research works. Member of Digital Pathology Association, Japan, Japanese Society of Pathology, Japanese Society of Clinical Cytology, Japanese Society of Toxicologic Pathology, and Japanese Cancer Association. He has over 200 peer reviewed research publications in oncological and experimental pathology and more than 20 book chapters to his credit. Currently he is involved in image analysis using deep learning and computer-aided detection/diagnosis in pathological cytological fields.
Cervical cancer is the fourth most common cancer in women worldwide. Although cytology or HPV testing is available for screening, these techniques have their drawbacks and optimal screening methods are still being developed. Here, we sought to det...
Acta histochemica et cytochemica 55(4) 111-118 2022年8月
Macrophages are classified into two phenotypes, M1 and M2, based on their roles. M2 macrophages suppress inflammation and increase in proportion to the malignancy of brain tumors. Recently, macrophage extracellular traps (METs), which change into ...
International journal of molecular sciences 23(12) 2022年6月
In recent years, the choice of immune checkpoint inhibitors (ICIs) as a treatment based on high expression of programmed death-ligand 1 (PD-L1) in lung cancers has been increasing in prevalence. The high expression of PD-L1 could be a predictor of...
Asian Pacific journal of cancer prevention : APJCP 23(4) 1315-1324 2022年4月 [査読有り]
OBJECTIVE: It is essential to accurately diagnose and classify histological subtypes into adenocarcinoma (ADC), squamous cell carcinoma (SCC), and small cell lung carcinoma (SCLC) for the appropriate treatment of lung cancer patients. However, imp...